COGT vs. CLSK

Last updated Apr 1, 2026

Compare and contrast key facts about Cogent Biosciences, Inc. (COGT) and CleanSpark, Inc. (CLSK).

Performance

COGT vs. CLSK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cogent Biosciences, Inc. (COGT) and CleanSpark, Inc. (CLSK). The values are adjusted to include any dividend payments, if applicable.

COGT vs. CLSK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
COGT Cogent Biosciences, Inc.	8.36%	355.38%	32.65%	-49.13%	34.73%	-23.60%	289.93%	-83.64%	-60.40%
CLSK CleanSpark, Inc.	-15.91%	9.88%	-16.50%	440.69%	-78.57%	-67.23%	442.99%	-73.90%	30.57%

Fundamentals

EPS COGT : -$3.33 CLSK : -$1.28
Total Revenue (TTM) COGT : $0.00 CLSK : $785.19M
Gross Profit (TTM) COGT : $0.00 CLSK : $256.57M
EBITDA (TTM) COGT : -$333.36M CLSK : $131.94M

Returns By Period

In the year-to-date period, COGT achieves a 8.36% return, which is significantly higher than CLSK's -15.91% return.

COGT

• 1D: 8.76%
• 1M: -0.93%
• YTD: 8.36%
• 6M: 168.04%
• 1Y: 542.57%
• 3Y*: 52.79%
• 5Y*: 33.49%
• 10Y*: —

CLSK

• 1D: 4.03%
• 1M: -14.47%
• YTD: -15.91%
• 6M: -41.31%
• 1Y: 26.64%
• 3Y*: 45.20%
• 5Y*: -18.02%
• 10Y*: -11.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

COGT vs. CLSK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COGT

COGT Risk / Return Rank: 99
COGT Sharpe Ratio Rank: 99
COGT Sortino Ratio Rank: 99
COGT Omega Ratio Rank: 98
COGT Calmar Ratio Rank: 99
COGT Martin Ratio Rank: 99

CLSK

CLSK Risk / Return Rank: 53
CLSK Sharpe Ratio Rank: 53
CLSK Sortino Ratio Rank: 59
CLSK Omega Ratio Rank: 55
CLSK Calmar Ratio Rank: 50
CLSK Martin Ratio Rank: 49

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COGT vs. CLSK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cogent Biosciences, Inc. (COGT) and CleanSpark, Inc. (CLSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	COGT	CLSK	Difference
Sharpe ratio Return per unit of total volatility	4.04	0.29	+3.75
Sortino ratio Return per unit of downside risk	6.26	1.11	+5.16
Omega ratio Gain probability vs. loss probability	1.80	1.12	+0.68
Calmar ratio Return relative to maximum drawdown	15.02	0.28	+14.74
Martin ratio Return relative to average drawdown	44.68	0.54	+44.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

COGT vs. CLSK - Sharpe Ratio Comparison

The current COGT Sharpe Ratio is 4.04, which is higher than the CLSK Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of COGT and CLSK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	COGT	CLSK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.04	0.29	+3.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.35	-0.18	+0.53
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.06	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.01	-0.06	+0.05

Correlation

The correlation between COGT and CLSK is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

COGT vs. CLSK - Dividend Comparison

Neither COGT nor CLSK has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

COGT vs. CLSK - Drawdown Comparison

The maximum COGT drawdown since its inception was -98.09%, roughly equal to the maximum CLSK drawdown of -98.56%. Use the drawdown chart below to compare losses from any high point for COGT and CLSK.

Drawdown Indicators

	COGT	CLSK	Difference
Max Drawdown Largest peak-to-trough decline	-98.09%	-98.56%	+0.47%
Max Drawdown (1Y) Largest decline over 1 year	-30.57%	-64.74%	+34.17%
Max Drawdown (5Y) Largest decline over 5 years	-76.34%	-92.25%	+15.91%
Max Drawdown (10Y) Largest decline over 10 years	—	-98.56%	—
Current Drawdown Current decline from peak	-42.62%	-88.34%	+45.72%
Average Drawdown Average peak-to-trough decline	-78.48%	-69.27%	-9.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.06%	33.98%	-22.92%

Volatility

COGT vs. CLSK - Volatility Comparison

The current volatility for Cogent Biosciences, Inc. (COGT) is 15.39%, while CleanSpark, Inc. (CLSK) has a volatility of 22.06%. This indicates that COGT experiences smaller price fluctuations and is considered to be less risky than CLSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	COGT	CLSK	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.39%	22.06%	-6.67%
Volatility (6M) Calculated over the trailing 6-month period	85.97%	70.97%	+15.00%
Volatility (1Y) Calculated over the trailing 1-year period	135.60%	91.62%	+43.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	95.11%	101.41%	-6.30%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	168.06%	184.30%	-16.24%

Financials